Taken together, our data suggest that down-regulation of piR-35127 and piR-46545 and up-regulation of piR-34871 and piR-52200 may promote cell proliferation of lung cancer cells and that this could be one potential mechanism through which RASSF1C contributes to oncogenesis and progression of lung cancer. This evidence concerns the gene PIR and lung carcinoma.